Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 25,800 KRW
Change Today -4,000.00 / -13.42%
Volume 377.0K
003220 On Other Exchanges
Symbol
Exchange
Korea SE
As of 2:28 AM 07/7/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for daewon pharmaceutical co ltd (003220)

View Cash Flow In U.S. Dollar
Currency in
Millions of South Korean Wons
As of:Dec 31
2011
Restated
KRW
Dec 31
2012
Restated
KRW
Dec 31
2013
Restated
KRW
Dec 31
2014
KRW
4 Year
Trend
NET INCOME9,436.49,614.812,320.915,728.5
Depreciation & Amortization2,705.92,927.13,227.03,534.6
Amortization of Goodwill and Intangible Assets739.5849.4815.2791.3
DEPRECIATION & AMORTIZATION, TOTAL3,445.43,776.54,042.14,325.9
(Gain) Loss from Sale of Asset115.110.6172.0-24.9
(Gain) Loss on Sale of Investment64.9737.763.5-235.9
Asset Writedown & Restructuring Costs600.0747.3766.1420.8
Other Operating Activities-2,804.04,494.14,561.06,148.6
Provision & Write-off of Bad Debts687.6440.4140.5--
Change in Accounts Receivable1,710.61,876.41,220.51,960.9
Change in Inventories-2,369.2-4,545.0-6,026.6-9,401.0
Change in Accounts Payable2,612.51,300.1-12.6-2,538.8
Change in Other Working Capital4,433.6-4,625.2-4,927.01,063.3
CASH FROM OPERATIONS17,932.713,827.712,320.517,447.4
Capital Expenditure-10,155.9-3,303.2-9,848.9-15,837.5
Sale of Property, Plant, and Equipment12.02.716.223.4
Cash Acquisitions-1,932.6------
Sale (Purchase) of Real Estate Properties-35.6------
Sale (Purchase) of Intangible Assets-1,130.9-44.6-133.8170.5
Investments in Marketable & Equity Securities-1,063.2---6,998.02,138.7
CASH FROM INVESTING-13,822.9-3,547.2-16,796.9-13,930.8
Short-Term Debt Issued3,080.6------
TOTAL DEBT ISSUED3,080.6------
Short Term Debt Repaid-3,000.0-3,200.0----
TOTAL DEBT REPAID-3,000.0-3,200.0----
Issuance of Common Stock1,000.0------
Repurchase of Common Stock---1.3-5.2-10.0
Common and/or Preferred Dividends Paid-2,458.9-637.9-701.7-1,157.7
TOTAL DIVIDEND PAID-2,458.9-637.9-701.7-1,157.7
Other Financing Activities-276.7-35.8197.5-106.0
CASH FROM FINANCING-1,655.0-3,875.0-509.4-1,273.7
Foreign Exchange Rate Adjustments-0.8-0.1---0.1
Miscellaneous Cash Flow Adjustments0.00.00.00.0
NET CHANGE IN CASH2,454.16,405.4-4,985.82,242.7
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
003220:KS 25,800.00 KRW -4,000.00

003220 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 003220.
View Industry Companies
 

Industry Analysis

003220

Industry Average

Valuation 003220 Industry Range
Price/Earnings 27.6x
Price/Sales 2.6x
Price/Book 3.7x
Price/Cash Flow 27.7x
TEV/Sales 2.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAEWON PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.